#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinopathy proliferative Wiskott-Aldrich syndrome Cluster headache Synovial sarcoma Familial amyotrophic lateral sclerosis Frostbite Mantle cell lymphoma Head and neck cancer Lip and/or oral cavity cancer Chronic graft versus host disease in intestine Paroxysmal nocturnal haemoglobinuria Bronchiolitis Myelofibrosis Penile squamous cell carcinoma Malignant oligodendroglioma More trials…

    Learn about Rare Diseases

    Factor IX deficiency – Life with Disease Congenital hypotransferrinaemia – Trials in Disease Anaplastic thyroid cancer – Treatment Ornithine transcarbamoylase deficiency Short-bowel syndrome – Life with Disease Mantle cell lymphoma refractory Idiopathic pulmonary fibrosis – Trials in Disease Basal cell naevus syndrome Noonan syndrome – Treatment Glycogen storage disease type I – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elotuzumab Certolizumab Pegol Mitomycin Brepocitinib Tosilate Cefixime Ioflupane (123I) Sotalol Namodenoson Bms-986315 Dimeticone NORELGESTROMIN ALG-000184 Ltx-315 Propofol Sirexatamab VORMATRIGINE Cilazapril Lysine Hydrochloride Skin Autograft Tezacaftor More therapies…

    Learn about Your Condition

    Skin papilloma Ankylosing spondylitis Cancer pain Thalassaemia beta Decreased appetite Fibrosarcoma metastatic Coma Biotinidase deficiency Richter's syndrome Behcet's syndrome EGFR gene mutation Choroidal neovascularisation Brain neoplasm Oropharyngeal cancer Procedural haemorrhage More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Estonia

  • Study Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Acasunlimab
    • Anakinra
    • Betamethasone Sodium Phosphate
    Austria Belgium Bulgaria Croatia Estonia France +9
  • Study on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis

    Not recruiting

    2 1
    Investigated Drugs:
    • AGA2118
    Bulgaria Denmark Estonia Poland
  • Study on the Long-Term Safety of Obeticholic Acid and Bezafibrate for Patients with Primary Biliary Cholangitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bezafibrate
    • Obeticholic Acid
    Belgium Croatia Czechia Estonia France Germany +6
  • Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Sonelokimab
    Bulgaria Croatia Czechia Estonia Finland France +10
  • Study on UGN-102 (Mitomycin) for Treating Low Grade Non-Muscle Invasive Bladder Cancer in Patients at Intermediate Risk of Recurrence

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bladder cancer
    Investigated Drugs:
    • Mitomycin
    Austria Bulgaria Estonia Latvia Lithuania Poland +1
  • Study Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Nivolumab
    Croatia Czechia Estonia France Germany Hungary +6
Previous Page
1 … 14 15 16 17 18 … 32
Next Page

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Cisplatin Dexamethasone Fluorouracil Risankizumab Durvalumab Hydrocortisone Prednisolone Oxaliplatin Prednisone Cytarabine Carboplatin Tocilizumab Mycophenolate Mofetil Venetoclax Etoposide Olaparib Upadacitinib Rosuvastatin Folinic Acid Pneumococcal Polysaccharide Serotype 11A Bortezomib Pneumococcal Polysaccharide Serotype 4 GSKVX000000025896 Calcium Folinate Pneumococcal Polysaccharide Serotype 12F Rituximab Pneumococcal Polysaccharide Serotype 5 VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26) Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acromegaly Acute coronary syndrome Acute kidney injury Acute lymphocytic leukaemia Acute myeloid leukaemia Acute myocardial infarction Adenocarcinoma gastric Adenocarcinoma of colon Adrenogenital syndrome Age-related macular degeneration Arteriosclerosis Asthma Atrial fibrillation Axial spondyloarthritis Bladder cancer Cardiac failure Cardiovascular disorder Cerebrovascular accident prophylaxis Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic kidney disease Chronic lymphocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Coagulation factor X level Colitis ulcerative Colorectal cancer metastatic Colorectal cancer stage IV Coronary artery disease Critical illness Crohn's disease Cytomegalovirus immunisation Dementia Alzheimer's type Dermatitis atopic Diabetic foot infection Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma refractory Dyslipidaemia Emphysema Encephalopathy neonatal Endocrine ophthalmopathy Endometrial cancer Factor IX deficiency Factor VIII deficiency Focal segmental glomerulosclerosis Follicular lymphoma Gastric cancer Generalised anxiety disorder Genital herpes simplex Glioblastoma multiforme Hepatocellular carcinoma Herpes simplex Herpes zoster Hormone-refractory prostate cancer Hypercholesterolaemia Idiopathic pulmonary fibrosis IgA nephropathy Influenza Influenza immunisation Interstitial lung disease Lupus nephritis Macular oedema Major depression Mantle cell lymphoma Metapneumovirus infection Metastatic malignant melanoma Microsatellite instability cancer Multifocal motor neuropathy Multiple sclerosis Multiple sclerosis relapse Myelodysplastic syndrome Neonatal asphyxia Neoplasm Neoplasm malignant Neovascular age-related macular degeneration Nephropathy Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Obesity Oesophageal adenocarcinoma Oesophageal carcinoma Orthostatic hypotension Osteoarthritis Osteoporosis postmenopausal Overweight Paroxysmal nocturnal haemoglobinuria PD-L1 positive cancer Plasma cell myeloma Plasma cell myeloma refractory Pneumococcal immunisation Pneumonia Pneumonia respiratory syncytial viral Primary biliary cholangitis Primary progressive multiple sclerosis Progressive relapsing multiple sclerosis Prophylaxis of nausea and vomiting Prostate cancer Prostate cancer recurrent Psoriasis Psoriatic arthropathy Pyelonephritis acute Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal disorder Respiratory syncytial virus bronchiolitis Respiratory syncytial virus bronchitis Respiratory syncytial virus infection Retinal vein occlusion Rheumatoid arthritis Richter's syndrome Secondary progressive multiple sclerosis Short-bowel syndrome Sjogren's syndrome Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Systemic lupus erythematosus Systemic scleroderma Thrombosis prophylaxis Type 1 diabetes mellitus Urinary tract infection Varicella

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!